Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Closes on Controlling Stake in Emory Genetics Laboratory

NEW YORK (GenomeWeb) – French genomic services firm Eurofins today announced it has successfully acquired a 75 percent stake in the Emory Genetics Laboratory.

The new company will be called EGL Genetic Diagnostics, and will operate as a joint venture of Eurofins and Emory University.

Eurofins said in a statement that the laboratory serves over 400 institutional clients across the US and expects to generate more than $15 million in revenues for the Fiscal Year 2015.

Eurofins announced in June that it would purchase the controlling stake in the lab. The firm also acquired Diatherix Laboratories that month.